MannKind (MNKD)
(Delayed Data from NSDQ)
$5.43 USD
-0.18 (-3.21%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.44 +0.01 (0.18%) 5:28 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MNKD 5.43 -0.18(-3.21%)
Will MNKD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MNKD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNKD
Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report?
New Strong Sell Stocks for August 27th
MNKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
MannKind (MNKD) Reports Break-Even Earnings for Q2
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for MNKD
Is MNKD showing upside potential? 180 Bullish Setup shows up after advancing 4.08%
MNKD forms MACD Bearish Signal Line Cross on September 17
MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target | MNKD Stock News
Insider Sell Alert: Stuart Tross Sells 47,000 Shares of MannKind Corp (MNKD)
Is MNKD signaling a buying opportunity? Hammer Candlestick shows up after slipping 0.19%